ProfileGDS4718 / 220843_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 21% 22% 23% 20% 37% 38% 23% 20% 27% 21% 11% 33% 40% 26% 21% 25% 37% 32% 21% 32% 24% 25% 25% 25% 41% 22% 35% 27% 24% 24% 27% 23% 26% 43% 31% 30% 26% 23% 20% 24% 27% 28% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2684123
GSM549102patient 115, normal, homogenized [OPG study]4.1838921
GSM549104patient 119, normal, homogenized [OPG study]4.210322
GSM549108patient 138, normal, homogenized [OPG study]4.3110123
GSM549119patient 077, normal, homogenized [OPG study]4.1481920
GSM549133patient 032, cancer, homogenized [OPG study]4.7830137
GSM549139patient 042, cancer, homogenized [OPG study]4.8935338
GSM549099patient 107, normal, homogenized [OPG study]4.2681523
GSM549109patient 139, normal, homogenized [OPG study]4.166820
GSM549110patient 046, normal, homogenized [OPG study]4.408827
GSM549114patient 063, normal, homogenized [OPG study]4.1456521
GSM549122patient 082, normal, homogenized [OPG study]3.8278711
GSM549134patient 033, cancer, homogenized [OPG study]4.6399633
GSM549136patient 036, cancer, homogenized [OPG study]4.9292940
GSM549140patient 044, cancer, homogenized [OPG study]4.3408526
GSM549111patient 047, normal, homogenized [OPG study]4.1641521
GSM549113patient 057, normal, homogenized [OPG study]4.2684925
GSM549132patient 031, cancer, homogenized [OPG study]4.8192937
GSM549137patient 038, cancer, homogenized [OPG study]4.6178632
GSM549142patient 047, cancer, homogenized [OPG study]4.2686621
GSM549100patient 110, normal, homogenized [OPG study]4.6355932
GSM549107patient 135, normal, homogenized [OPG study]4.2832924
GSM549115patient 068, normal, homogenized [OPG study]4.2779825
GSM549116patient 072, normal, homogenized [OPG study]4.3233425
GSM549120patient 078, normal, homogenized [OPG study]4.3513925
GSM549131patient 030, cancer, homogenized [OPG study]4.9871141
GSM549118patient 074, normal, homogenized [OPG study]4.2432222
GSM549129patient 027, cancer, homogenized [OPG study]4.7717235
GSM549123patient 088, normal, homogenized [OPG study]4.3837427
GSM549124patient 006, cancer, homogenized [OPG study]4.3423524
GSM549126patient 015, cancer, homogenized [OPG study]4.2922524
GSM549128patient 025, cancer, homogenized [OPG study]4.4018327
GSM549103patient 117, normal, homogenized [OPG study]4.2855323
GSM549117patient 073, normal, homogenized [OPG study]4.3384126
GSM549138patient 041, cancer, homogenized [OPG study]5.143943
GSM549141patient 045, cancer, homogenized [OPG study]4.5283731
GSM549130patient 028, cancer, homogenized [OPG study]4.5698630
GSM549101patient 111, normal, homogenized [OPG study]4.4124726
GSM549105patient 128, normal, homogenized [OPG study]4.2931823
GSM549106patient 134, normal, homogenized [OPG study]4.0917120
GSM549112patient 048, normal, homogenized [OPG study]4.2747724
GSM549125patient 011, cancer, homogenized [OPG study]4.4401427
GSM549127patient 024, cancer, homogenized [OPG study]4.4248528
GSM549135patient 035, cancer, homogenized [OPG study]5.0211442